Classification turns on product nature and technical evidence: bulk drugs sold in small packs stay under Chapter 29, with Modvat credit allowed.

Ethyl Chloride IP-100 ml and Anaesthetic Ether IP-500 ml were held classifiable as bulk drugs under Chapter 29, not as medicaments under Chapter 30, because classification followed the true nature of the goods, the licensing description and technical opinion from drug authorities; small retail packing did not alter that character. On that basis, the assessee was also entitled to Modvat credit on duty-paid inputs used in manufacture, as the goods were correctly treated as excisable under Chapter 29 and cleared on payment of duty. The appellate order was annulled, the adjudicating authority's view restored, and the appeals succeeded with consequential relief.

---

---

Issues: (i) Whether the products Ethyl Chloride IP-100 ml and Anaesthetic Ether IP-500 ml were classifiable as bulk drugs under Chapter 29 or as medicaments under Chapter 30. (ii) Whether the assessee was entitled to Modvat credit on the duty paid inputs used in the manufacture of the products.

Issue (i): Whether the products Ethyl Chloride IP-100 ml and Anaesthetic Ether IP-500 ml were classifiable as bulk drugs under Chapter 29 or as medicaments under Chapter 30.

Analysis: The classification was determined on the basis of the nature of the goods, the opinion of the Deputy Director, Food & Drugs Administration, and the licensing description. The authority found that the products were treated by the drug authorities as bulk drugs and that mere marketing in small bottles did not convert them into medicaments. In the absence of material displacing that technical opinion, the contrary classification under Chapter 30 was not accepted.

Conclusion: The products were classifiable under Chapter 29 and not under Chapter 30.

Issue (ii): Whether the assessee was entitled to Modvat credit on the duty paid inputs used in the manufacture of the products.

Analysis: Once the goods were held to be bulk drugs falling under Chapter 29 and cleared on payment of duty, the credit on inputs used in their manufacture followed under the applicable Modvat scheme.

Conclusion: The assessee was entitled to Modvat credit.

Final Conclusion: The impugned appellate order was annulled, the adjudicating authority's view was restored, and the appeals succeeded with consequential relief.

Ratio Decidendi: Classification must follow the true nature of the product and reliable technical evidence, and goods established as bulk drugs cannot be treated as medicaments merely because they are sold in small retail packs; duty paid input credit is available where such goods are cleared under the correct excisable classification.

---